Mankind Pharma Ltd (MANKIND) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.105x

Based on the latest financial reports, Mankind Pharma Ltd (MANKIND) has a cash flow conversion efficiency ratio of 0.105x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Rs16.37 Billion ≈ $177.00 Million USD) by net assets (Rs155.29 Billion ≈ $1.68 Billion USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see MANKIND stock market capitalisation for the company's overall valuation and market capitalisation.

Mankind Pharma Ltd - Cash Flow Conversion Efficiency Trend (2019–2026)

This chart illustrates how Mankind Pharma Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Mankind Pharma Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Mankind Pharma Ltd ranked by their cash flow conversion efficiency. Explore MANKIND operating cash flow to net income to measure how well operating cash flow supports reported net income.

Company	Cash Flow Conversion Efficiency
WOORI FIN. GRP SP.ADR/3 F:2WGA	0.311x
Tempus AI, Inc. Class A Common Stock NASDAQ:TEM	-0.017x
Chongqing Sokon Ind Grp Co SHG:601127	0.287x
Banco Santander (Brasil) S.A. SA:SANB3	0.200x
Sanmina Corporation NASDAQ:SANM	0.045x
Elanco Animal Health NYSE:ELAN	0.044x
CSPC PHARMACEUT.GR. ADR4 F:CVGU	N/A
REXEL S.A. ADR EO 5 F:E7V0	N/A

Annual Cash Flow Conversion Efficiency for Mankind Pharma Ltd (2019–2026)

The table below shows the annual cash flow conversion efficiency of Mankind Pharma Ltd from 2019 to 2026. View Mankind Pharma Ltd stock quote for real-time trading data and today's change.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2026-03-31	Rs165.61 Billion ≈ $1.79 Billion	Rs25.16 Billion ≈ $272.06 Million	0.152x	-8.30%
2025-03-31	Rs145.68 Billion ≈ $1.58 Billion	Rs24.13 Billion ≈ $261.00 Million	0.166x	-26.30%
2024-03-31	Rs95.76 Billion ≈ $1.04 Billion	Rs21.52 Billion ≈ $232.78 Million	0.225x	-5.18%
2023-03-31	Rs76.49 Billion ≈ $827.19 Million	Rs18.13 Billion ≈ $196.10 Million	0.237x	+62.80%
2022-03-31	Rs63.16 Billion ≈ $683.08 Million	Rs9.20 Billion ≈ $99.47 Million	0.146x	-37.73%
2021-03-31	Rs48.63 Billion ≈ $525.90 Million	Rs11.37 Billion ≈ $122.99 Million	0.234x	-19.73%
2020-03-31	Rs36.72 Billion ≈ $397.07 Million	Rs10.70 Billion ≈ $115.68 Million	0.291x	+44.69%
2019-03-31	Rs29.82 Billion ≈ $322.46 Million	Rs6.00 Billion ≈ $64.93 Million	0.201x	--

About Mankind Pharma Ltd

NSE:MANKIND India Drug Manufacturers - Specialty & Generic

Market Cap

$11.06 Billion

Rs1.02 Trillion INR

Market Cap Rank

#2063 Global

#83 in India

Share Price

Rs2474.90

Change (1 day)

-1.00%

52-Week Range

Rs1927.40 - Rs2617.90

All Time High

Rs2998.40